CountryOfPapers CountryOfPapers
Journal list Promote
verified COP 10,7 · D1 • database Scopus / SJR & Web of Science indexed
The Lancet Neurology
United Kingdom · Elsevier Ltd
workspace_premium D1 Top 10% — Neurology (clinical) lock_open Open Access

The Lancet Neurology

The Lancet Neurology is a journal indexed in SJR in Neurology (clinical) with an H index of 379. It has a COP Index of 10,7 (best band D1). It is published in English. It has a COP Index of 10,7.

The Lancet Neurology focuses its scope in these topics and keywords: disease, disorders, diagnosis, multiple, patients, sporadic, cerebral, traumatic, reality, brain, ...

ISSN: 1474-4422
Publisher: Elsevier Ltd
Category: Neurology (clinical)
Indexation: verifiedScopus / SJR verifiedWeb of Science
open_in_new Portal NPD menu_book Guidelines NPD
schedule CountryOfPapers database fields
COP Index trending_up
10,7 D1 Top 10%

4 of 336 journals in Neurology (clinical)

H-index · SJR 379 · 11,729
Acceptance rate pie_chart
17% Selective
Source Acceptance_Rate
Time to publication hourglass_top
NPD
Field NPD
Publication cost (APC) payments
NPD Open Access
Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

COP Index

10,7

D1 Top 10%

SJR Impact

11,729

H-index

379

Docs (year)

326

Docs 3y

809

Total refs

5398

Cites 3y

9796

Citable 3y

288

Cites/Doc 2y

10.2

Ref/Doc

16.56

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Cancer stem cells may drive growth of paediatric brain tumours

View more

Yeast studies provide clues to neurodegeneration

View more

Diagnostic pitfalls in eosinophilic cryptococcal meningoencephalitis

View more

Determining death

View more

Cytokines in sudden infant death syndrome

View more

Current approaches to the identification and management of breakthrough disease in patients with multiple sclerosis

View more

cPLA2: common link in the pathogenesis of multiple sclerosis

View more

Cost-benefit analysis for epilepsy surgery

View more

Cocaine use may damage dopaminergic system

View more

Clazosentan for patients with subarachnoid haemorrhage: lessons learned -Authors' reply

View more

Clazosentan for patients with subarachnoid haemorrhage: lessons learned

View more

Chris Polman: quietly making multiple sclerosis research tick

View more
SHOW MORE ARTICLES

Caring about caring

View more

A child's eye view

View more

Breaking the diagnosis of dementia

View more

Brain Imaging in Epilepsy

View more

Antiprogesterone hope for inherited neuropathy

View more

Anticysticercal treatment and seizures in neurocysticercosis

View more

Alcoholism damages the brain, but does moderate alcohol use?

View more

AIDS and stroke risk

View more

Adult neural stem cells localised in SVZ

View more

Acetylcholine and memory formation

View more

A Wellcome relief

View more

A spoonful of trehalose makes the protein aggregations go down

View more

FAQs